BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30717342)

  • 1. Effect of Pullet Vaccination on Development and Longevity of Immunity.
    Aston EJ; Jordan BJ; Williams SM; García M; Jackwood MW
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30717342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection induced by infectious laryngotracheitis virus vaccines alone and combined with Newcastle disease virus and/or infectious bronchitis virus vaccines.
    Vagnozzi A; García M; Riblet SM; Zavala G
    Avian Dis; 2010 Dec; 54(4):1210-9. PubMed ID: 21313841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges.
    Zhao W; Spatz S; Zhang Z; Wen G; Garcia M; Zsak L; Yu Q
    J Virol; 2014 Aug; 88(15):8397-406. PubMed ID: 24829337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.
    Cavanagh D
    Avian Pathol; 2003 Dec; 32(6):567-82. PubMed ID: 14676007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoprotein-C-gene-deleted recombinant infectious laryngotracheitis virus expressing a genotype VII Newcastle disease virus fusion protein protects against virulent infectious laryngotracheitis virus and Newcastle disease virus.
    Wei X; Shao Y; Han Z; Sun J; Liu S
    Vet Microbiol; 2020 Nov; 250():108835. PubMed ID: 33011664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative protective immunity provided by live vaccines of Newcastle disease virus or avian metapneumovirus when co-administered alongside classical and variant strains of infectious bronchitis virus in day-old broiler chicks.
    Ball C; Forrester A; Herrmann A; Lemiere S; Ganapathy K
    Vaccine; 2019 Dec; 37(52):7566-7575. PubMed ID: 31607602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambient ammonia does not appear to inhibit the immune response to infectious bronchitis virus vaccination and protection from homologous challenge in broiler chickens.
    Aston EJ; Jackwood MW; Gogal RM; Hurley DJ; Fairchild BD; Hilt DA; Cheng S; Tensa LR; Garcia M; Jordan BJ
    Vet Immunol Immunopathol; 2019 Nov; 217():109932. PubMed ID: 31472338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
    Kanabagatte Basavarajappa M; Kumar S; Khattar SK; Gebreluul GT; Paldurai A; Samal SK
    Vaccine; 2014 Jun; 32(28):3555-63. PubMed ID: 24793943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating viral interference between infectious bronchitis virus and Newcastle disease virus vaccine strains using quantitative reverse transcription-polymerase chain reaction.
    Gelb J; Ladman BS; Licata MJ; Shapiro MH; Campion LR
    Avian Dis; 2007 Dec; 51(4):924-34. PubMed ID: 18251404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term protection against a virulent field isolate of infectious laryngotracheitis virus induced by inactivated, recombinant, and modified live virus vaccines in commercial layers.
    Palomino-Tapia VA; Zavala G; Cheng S; García M
    Avian Pathol; 2019 Jun; 48(3):209-220. PubMed ID: 30640536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Infectious Bronchitis Viruses Expressing Chimeric Spike Glycoproteins Induce Partial Protective Immunity against Homologous Challenge despite Limited Replication
    Ellis S; Keep S; Britton P; de Wit S; Bickerton E; Vervelde L
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious bronchitis virus S2 expressed from recombinant virus confers broad protection against challenge.
    Toro H; Zhao W; Breedlove C; Zhang Z; Yu Q; Van Santen V
    Avian Dis; 2014 Mar; 58(1):83-9. PubMed ID: 24758118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant infectious bronchitis virus (IBV) H120 vaccine strain expressing the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) protects chickens against IBV and NDV challenge.
    Yang X; Zhou Y; Li J; Fu L; Ji G; Zeng F; Zhou L; Gao W; Wang H
    Arch Virol; 2016 May; 161(5):1209-16. PubMed ID: 26873815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant infectious laryngotracheitis virus expressing Newcastle disease virus F protein protects chickens against infectious laryngotracheitis virus and Newcastle disease virus challenge.
    Shao Y; Sun J; Han Z; Liu S
    Vaccine; 2018 Dec; 36(52):7975-7986. PubMed ID: 30448332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited Protection Conferred by Recombinant Newcastle Disease Virus Expressing Infectious Bronchitis Spike Protein.
    Zegpi RA; He L; Yu Q; Joiner KS; van Santen VL; Toro H
    Avian Dis; 2020 Mar; 64(1):53-59. PubMed ID: 32267125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses and interactions following simultaneous application of live Newcastle disease, infectious bronchitis and avian metapneumovirus vaccines in specific-pathogen-free chicks.
    Awad F; Forrester A; Baylis M; Lemiere S; Jones R; Ganapathy K
    Res Vet Sci; 2015 Feb; 98():127-33. PubMed ID: 25482324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection Efficacy of Recombinant HVT-ND-LT and the Live Attenuated Tissue Culture Origin Vaccines Against Infectious Laryngotracheitis Virus When Administered Individually or in Combination.
    Becerra R; Maekawa D; García M
    Avian Dis; 2023 Jun; 67(2):145-152. PubMed ID: 37556293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of live virus vaccines against infectious laryngotracheitis assessed by polymerase chain reaction-restriction fragment length polymorphism.
    Han MG; Kim SJ
    Avian Dis; 2003; 47(2):261-71. PubMed ID: 12887186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a sensitive and specific xMAP assay for detection of antibodies against infectious laryngotracheitis and bronchitis viruses.
    Wang H; Cong F; Guan J; Xiao L; Zhu Y; Lian Y; Huang R; Chen M; Guo P
    Virol J; 2018 Sep; 15(1):146. PubMed ID: 30241540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.